Brain-Computer Interface - ONWARD Medical

ARC^BCI is our investigational system that pairs ARC^IM Therapy with a brain-computer interface (BCI) to restore thought-driven movement

The ARC^BCI System creates the ONWARD DigitalBridge^™, reconnecting communication between the brain and the body to restore thought-driven movement after paralysis.

The ARC^BCI System has been awarded US FDA Breakthrough Device Designation, the 10th such award for an ONWARD Medical technology or therapy. ONWARD is also one of the first neurotechnology companies invited to join the FDA’s Total Product Life Cycle Advisory (TAP) Program, providing early and frequent strategic engagement with the FDA and other stakeholders.

The ARC^BCI System uses artificial intelligence (AI) to decode a person’s brain signals and translate their movement intentions into instructions for our ARC^IM System. The ARC^IM System then delivers precise spinal cord stimulation to restore thought-driven movement after paralysis.

The ARC^BCI System creates the ONWARD DigitalBridge^™, reconnecting communication between the brain and the body to restore thought-driven movement after paralysis.

The ARC^BCI System has been awarded US FDA Breakthrough Device Designation, the 10th such award for an ONWARD Medical technology or therapy. ONWARD is also one of the first neurotechnology companies invited to join the FDA’s Total Product Life Cycle Advisory (TAP) Program, providing early and frequent strategic engagement with the FDA and other stakeholders.

The ARC^BCI System uses artificial intelligence (AI) to decode a person’s brain signals and translate their movement intentions into instructions for our ARC^IM System. The ARC^IM System then delivers precise spinal cord stimulation to restore thought-driven movement after paralysis.

As part of a research consortium, in 2021 we successfully implanted the first investigational BCI in a human to enable thought-driven movement of the legs after paralysis. The results were published in Nature in May 2023.

In 2024, we secured exclusive rights to the WIMAGINE® BCI platform. WIMAGINE is a premier BCI technology with more than seven years of human safety data. The platform was originally developed by the prestigious French biomedical research institute, CEA-Clinatec. ONWARD now has the exclusive rights to develop and commercialize WIMAGINE as part of our ARC^BCI System.

Through mid-2025, we have successfully implanted five humans with ARC^BCI Therapy to facilitate mobility (walking) and upper extremity movement.

We expect to advance research and technology development of the ARC^BCI System in the coming years, supported by grants from the Christopher & Dana Reeve Foundation and European Innovation Council.

Learn more

As part of a research consortium, in 2021 we successfully implanted the first investigational BCI in a human to enable thought-driven movement of the legs after paralysis. The results were published in Nature in May 2023.

In 2024, we secured exclusive rights to the WIMAGINE® BCI platform. WIMAGINE is a premier BCI technology with more than seven years of human safety data. The platform was originally developed by the prestigious French biomedical research institute, CEA-Clinatec. ONWARD now has the exclusive rights to develop and commercialize WIMAGINE as part of our ARC^BCI System.

Through mid-2025, we have successfully implanted five humans with ARC^BCI Therapy to facilitate mobility (walking) and upper extremity movement.

We expect to advance research and technology development of the ARC^BCI System in the coming years, supported by grants from the Christopher & Dana Reeve Foundation and European Innovation Council.
Learn more

Please complete this form to
contact us or receive updates

Complete form

The ONWARD^® Medical ARC^EX® System is cleared for use only in the United States. ONWARD ARC^IM® and ARC^BCI™, alone or in combination with a brain-computer interface (BCI), are investigational and not available for commercial use.

Meet Gert-Jan and learn about his journey

ARCBCI

The ARCBCI System creates the ONWARD DigitalBridge™, reconnecting communication between the brain and the body to restore thought-driven movement after paralysis.

The ARCBCI System creates the ONWARD DigitalBridge™, reconnecting communication between the brain and the body to restore thought-driven movement after paralysis.

Please complete this form to contact us or receive updates

The ONWARD® Medical ARCEX® System is cleared for use only in the United States. ONWARD ARCIM® and ARCBCI™, alone or in combination with a brain-computer interface (BCI), are investigational and not available for commercial use.

ARC^BCI

The ARC^BCI System creates the ONWARD DigitalBridge^™, reconnecting communication between the brain and the body to restore thought-driven movement after paralysis.

The ARC^BCI System creates the ONWARD DigitalBridge^™, reconnecting communication between the brain and the body to restore thought-driven movement after paralysis.

Please complete this form to
contact us or receive updates

The ONWARD^® Medical ARC^EX® System is cleared for use only in the United States. ONWARD ARC^IM® and ARC^BCI™, alone or in combination with a brain-computer interface (BCI), are investigational and not available for commercial use.